Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme

By Peereboom David   Shepard Dale   Ahluwalia Manmeet   Brewer Cathy   Agarwal Neeraj   Stevens Glen   Suh John   Toms Steven   Vogelbaum Michael   Weil Robert   Elson Paul   Barnett Gene  

Journal of Neuro-Oncology, Vol. 98, Iss. 1, 2010-05 ,pp. : 93-99

Springer Publishing Company

Access to resources Recommend Favorite

A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme

By Groves Morris   Puduvalli Vinay   Chang Susan   Conrad Charles   Gilbert Mark   Tremont-Lukats Ivo   Liu Ta-Jen   Peterson Pamela   Schiff David   Cloughesy Timothy   Wen Patrick   Greenberg Harry   Abrey Lauren   DeAngelis Lisa   Hess Kenneth   Lamborn Kathleen   Prados Michael   Yung W.  

Journal of Neuro-Oncology, Vol. 81, Iss. 3, 2007-02 ,pp. : 271-277

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM)

By Balaña Carmen   López-pousa Antonio   Berrocal Alfonso   Yaya-tur Ricardo   Herrero Ana   García Jose-luis   Martín-broto Javier   Benavides Manuel   Cerdá-nicolás Miguel   Ballester Rosa   Balart Josep   Capellades Jaume  

Journal of Neuro-Oncology, Vol. 70, Iss. 3, 2004-12 ,pp. : 359-370

Springer Publishing Company

Access to resources Recommend Favorite

Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme

By Banna Giuseppe   Bettio Daniela   Scorsetti Marta   Navarria Pierina   Simonelli Matteo   Rodriguez Baena Riccardo   Aimar Enrico   Gaetani Paolo   Colombo PierGiuseppe   Rognone Felice   Santoro Armando  

Journal of Neuro-Oncology, Vol. 81, Iss. 3, 2007-02 ,pp. : 323-325

Springer Publishing Company

Access to resources Recommend Favorite

Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study

By Ardon Hilko   Gool Stefaan   Lopes Isabel   Maes Wim   Sciot Raf   Wilms Guido   Demaerel Philippe   Bijttebier Patricia   Claes Laurence   Goffin Jan   Calenbergh Frank   Vleeschouwer Steven  

Journal of Neuro-Oncology, Vol. 99, Iss. 2, 2010-09 ,pp. : 261-272

Springer Publishing Company

Access to resources Recommend Favorite